Related Experiment Video
Updated: May 9, 2026
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
miR-24-3p and miR-484 are potential biomarkers for neurodegeneration in multiple sclerosis
Rabeah Al-Temaimi1, Raed Alroughani2
1Human Genetics Unit, Department of Pathology, College of Medicine, Kuwait University, Jabriya, Kuwait.
Abstract:
Multiple sclerosis (MS) is a complex, neurodegenerative chronic disorder. Circulating diagnostic biomarkers for MS have remained elusive, and those proposed so far have limited sensitivity and specificity to MS. Plasma-circulating microRNAs (miRNAs) have advantageous biochemical and physiological attributes that can be utilized in clinical testing and disease monitoring. MS miRNA expression microarray datasets analysis resulted in four candidate miRNAs that were assessed for their expression in a separate MS case-control study. Only miR-24-3p was downregulated in all MS patients compared to healthy controls. MiR-484 was significantly upregulated in relapsing-remitting MS (RRMS) patients compared to healthy controls. Mir-146-5p and miR-484 were significantly downregulated in secondary-progressive MS (SPMS) compared to RRMS. MiR-484 downregulation was associated with worsening disability and increased lipocalin-2 levels. Mir-342-3p and miR-24-3p downregulation were associated with increased semaphorin-3A levels in MS and RRMS patients. In conclusion, mir-24-3p downregulation is diagnostic of MS, and mir-484 upregulation and downregulation are potential biomarkers for RRMS and SPMS conversion, respectively. The differential expression of miR-146a-3p in MS subtypes suggests its potential as an SPMS transition biomarker. The association of downregulated mir-24-3p and mir-484 with increased neurodegeneration biomarkers suggests they play a role in MS pathogenesis and neurodegeneration.
Insights
Downregulated miR-24-3p is a diagnostic biomarker for multiple sclerosis (MS). Specific microRNA changes may indicate relapsing-remitting MS or secondary-progressive MS conversion, aiding disease monitoring.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Multiple sclerosis (MS) is a chronic, neurodegenerative disorder with elusive diagnostic biomarkers.
- Current biomarkers lack sufficient sensitivity and specificity for MS diagnosis and monitoring.
- Plasma-circulating microRNAs (miRNAs) offer potential as accessible biomarkers due to their stability and detectability.
Purpose of the Study:
- To identify and validate circulating microRNAs as diagnostic and prognostic biomarkers for multiple sclerosis (MS).
- To investigate the differential expression of specific miRNAs in MS subtypes, including relapsing-remitting MS (RRMS) and secondary-progressive MS (SPMS).
- To explore the association between miRNA expression levels and clinical parameters, such as disability and neurodegeneration markers.
Main Methods:
- Analysis of MS miRNA expression microarray datasets to identify candidate miRNAs.
- Validation of candidate miRNA expression in a separate MS case-control study using quantitative methods.
- Correlation analysis of miRNA expression with clinical data, including disability scores and neurodegeneration biomarkers like lipocalin-2 and semaphorin-3A.
Main Results:
- miR-24-3p was significantly downregulated in all MS patients compared to healthy controls, indicating its diagnostic potential.
- miR-484 showed differential expression: upregulated in RRMS patients and downregulated in SPMS patients compared to RRMS.
- Downregulation of miR-24-3p and miR-484 correlated with increased levels of neurodegeneration markers, suggesting a role in MS pathogenesis.
Conclusions:
- Downregulation of miR-24-3p serves as a diagnostic biomarker for multiple sclerosis (MS).
- miR-484 expression patterns may distinguish between RRMS and SPMS, potentially serving as a biomarker for disease progression and conversion.
- Differential expression of miR-146a-3p in MS subtypes suggests its utility as a biomarker for SPMS transition.
